Chemical Compound

Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1); Dabrafenib mesylate; GSK 2118436 methanesulfonate salt; GSK 2118436B; N-[3-[5-(2-Aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide methanesulfonic acid; GSK 2118436B

CAS Registry Number 1195768-06-9
Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1); Dabrafenib mesylate; GSK 2118436 methanesulfonate salt; GSK 2118436B; N-[3-[5-(2-Aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide methanesulfonic acid; GSK 2118436B 结构式
Primary record

Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1); Dabrafenib mesylate; GSK 2118436 methanesulfonate salt; GSK 2118436B; N-[3-[5-(2-Aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide methanesulfonic acid; GSK 2118436B

库存
6,330 克
纯度
98.3 %
CAS
1195768-06-9

化合物标识与属性

CAS
1195768-06-9
PubChem CID
44516822
SMILES
CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F.CS(=O)(=O)O
Canonical SMILES
CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1.CS(=O)(=O)O

名称与同义词

  • Dabrafenib mesylate
  • 1195768-06-9
  • Tafinlar
  • Taflinar
  • dabrafenib mesilate
  • Dabrafenib (Mesylate)
  • (R)-Monophos
  • dabrafenib monomesylate
  • Tafinlar (TN)
  • Dabrafenib Mesylate?
  • Dabrafenib methanesulfonate
  • UNII-B6DC89I63E
  • Dabrafenib mesylate [USAN]
  • GSK-2118436 mesylate
  • METHANE SULFONATE SALT
  • RefChem:58041
  • B6DC89I63E
  • GSK 2118436B
  • GSK-2118436B
  • MFCD20922872
  • Dabrafenib mesilate (JAN)
  • GSK2118436 Mesylate
  • GSK2118436B
  • Dabrafenib mesylate (USAN)
  • GSK-2118436B MESYLATE
  • CHEBI:75048
  • GSK 2118436 Mesylate
  • DTXSID70152500
  • GSK2118436 Methane sulfonate salt
  • orb1298903
  • SCHEMBL1127269
  • CHEMBL2105729
  • DABRAFENIB MESYLATE [MI]
  • DTXCID3074991
  • SCHEMBL29352214
  • C24H24F3N5O5S3
  • DABRAFENIB MESILATE [JAN]
  • GSK 2118436
  • GSK2118436B, methane sulfonate salt
  • YKGMKSIHIVVYKY-UHFFFAOYSA-N
  • GLXC-90125
  • HMS5084M19
  • AMY30045
  • AOB87316
  • BCP04738
  • Dabrafenib Mesylate (GSK-2118436)
  • EX-A1559
  • 1195768-06-9 (mesylate)
  • ARD193678
  • DABRAFENIB MESILATE [WHO-DD]
  • GSK-2118436 METHANESULFONATE SALT
  • GSK-2118436A
  • HY-14660A
  • s5069
  • GSK-2118436B METHANESULFONATE SALT
  • AKOS025396661
  • ACN-041337
  • CCG-270246
  • CS-1641
  • Dabrafenib Mesylate(GSK-2118436B)
  • EBC-101133
  • Dabrafenib Mesylate (GSK-2118436B)
  • GSK-2118436
  • KS-00000T33
  • DABRAFENIB MESYLATE [ORANGE BOOK]
  • GSK2118436 Mesylate;GSK 2118436B
  • AC-31302
  • AS-17010
  • DA-72536
  • FD158016
  • SC-14698
  • SY260049
  • N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate
  • AK00739757
  • FT-0696677
  • A15059
  • D10104
  • A903491
  • SR-01000941590
  • Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1)
  • SR-01000941590-1
  • Q27145089
  • GSK2118436 Ms salt, Dabrafenib Ms salt, GSK2118436A Ms salt
  • N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide;methanesulfonic acid
  • BENZENESULFONAMIDE, N-(3-(5-(2-AMINO-4-PYRIMIDINYL)-2-(1,1-DIMETHYLETHYL)-4-THIAZOLYL)- 2-FLUOROPHENYL)-2,6-DIFLUORO-, METHANESULFONATE (1:1)
  • BENZENESULFONAMIDE, N-(3-(5-(2-AMINO-4-PYRIMIDINYL)-2-(1,1-DIMETHYLETHYL)-4-THIAZOLYL)-2-FLUOROPHENYL)-2,6-DIFLUORO-, METHANESULFONATE (1:1)
  • Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-, methanesulfonate (1:1); Dabrafenib mesylate; GSK 2118436 methanesulfonate salt; GSK 2118436B; N-[3-[5-(2-Aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide methanesulfonic acid; GSK 2118436B
  • Methanesulfonic acid--N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzene-1-sulfonamide (1/1)
  • N-(3-(5-(2-AMINOPYRIMIDIN-4-YL)-2-(1,1-DIMETHYLETHYL)THIAZOL-4-YL)-2-FLUOROPHENYL)-2,6- DIFLUOROBENZENESULFONAMIDE MONOMETHANESULFONATE
  • N-(3-(5-(2-AMINOPYRIMIDIN-4-YL)-2-(1,1-DIMETHYLETHYL)THIAZOL-4-YL)-2-FLUOROPHENYL)-2,6-DIFLUOROBENZENESULFONAMIDE MONOMETHANESULFONATE
  • N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide methanesulfonate
  • N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide Methanesulfonate
  • N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide,methanesulfonic acid
  • N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-thiazol-4-yl]-2-fluoro-phenyl]-2,6-difluoro-benzenesulfonamide methanesulfonic acid
  • N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-thiazol-4-yl]-2-fluoro-phenyl]-2,6-difluoro-benzenesulfonamide;methanesulfonic acid
  • N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide methanesulfonate
  • N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide methanesulfonate